Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000

被引:135
作者
Tanaka, J
Kumagai, J
Katayama, K
Komiya, Y
Mizui, M
Yamanaka, R
Suzuki, K
Miyakawa, Y
Yoshizawa, H
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Epidemiol & Control Infect Dis, Minami Ku, Hiroshima 7348551, Japan
[2] Japanese Red Cross Hiroshima Blood Ctr, Hiroshima, Japan
[3] Japanese Red Cross Assoc, Tokyo, Japan
[4] Miyakawa Mem Res Fdn, Tokyo, Japan
关键词
hepatitis B virus; hepatitis C virus; hepatocellular carcinoma; transfusion;
D O I
10.1159/000076640
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Objective: Carriers of hepatitis B virus (HBV) and hepatitis C virus (HCV) in Japan were estimated on a national basis. Methods: Sera from the first-time blood donors aged 16 - 64 years in eight jurisdictions of the Japanese Red Cross Blood Center during 1995 - 2000 were tested for hepatitis B surface antigen ( HBsAg) and antibody to HCV (anti-HCV). Viremia with HCV was estimated to be present in 70% of donors with anti-HCV. Results: HBsAg was detected in 22,018 of 3,485,648 ( 0.63%) blood donors including 12,990 of 1,780,149 (0.73%) men and 9,028 of 1,705,499 (0.53%) women, and anti-HCV in 17,010 (0.49%) including 8,504 (0.48%) men and 8,506 (0.50%) women. Multiplying the carrier rate by the population registered in the Census 2000, the total HBV carriers aged 15 - 65 years were estimated at 967,753 (95% confidence interval 806,760 - 1,128,745), of whom 571,210 ( 479,267 - 663,152) were men and 396,543 ( 327,494 - 465,593) were women. Likewise, the total HCV carriers were estimated at 884,954 (95% confidence interval 725,082 - 1,044,826), of whom 464,363 ( 377,927 550,799) were men and 420,591 ( 347,156 - 494,027) were women. Conclusion: Estimated numbers of HBV and HCV carriers would help plan to prevent the development of hepatocellular carcinoma in Japan. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:32 / 40
页数:9
相关论文
共 23 条
[1]   Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome [J].
Alter, HJ ;
Seeff, LB .
SEMINARS IN LIVER DISEASE, 2000, 20 (01) :17-35
[2]   COMPARISON OF 2 2ND-GENERATION ANTI-HEPATITIS-C VIRUS ELISA ON 21431 US BLOOD-DONOR SAMPLES [J].
ANDERSON, SC ;
HATHAWAY, T ;
KURAMOTO, IK ;
HOLLAND, PV ;
GILCHER, R ;
KOCH, T ;
HOJVAT, S .
JOURNAL OF VIRAL HEPATITIS, 1995, 2 (01) :55-61
[3]   Porphyria cutanea tarda and hepatitis C virus: A case-control study and meta-analysis of the literature [J].
Chuang, TY ;
Brashear, R ;
Lewis, C .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 41 (01) :31-36
[4]   The scientific challenge of hepatitis C [J].
Cohen, J .
SCIENCE, 1999, 285 (5424) :26-30
[5]   Risk factors for the rising rates of primary liver cancer in the United States [J].
El-Serag, HB ;
Mason, AC .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (21) :3227-3230
[6]   Hepatocellular carcinoma - An epidemiologic view [J].
El-Serag, HB .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 35 (05) :S72-S78
[7]  
KIYOSAWA K, 2002, ONCOLOGY, V62, pS5
[8]   Prevention of perinatal hepatitis B virus transmission by combined passive-active immunoprophylaxis in Iwate, Japan (1981-1992) and epidemiological evidence for its efficacy [J].
Koyama, T ;
Matsuda, I ;
Sato, S ;
Yoshizawa, H .
HEPATOLOGY RESEARCH, 2003, 26 (04) :287-292
[9]   Hepatitis C: an epidemiological review [J].
Memon, MI ;
Memon, MA .
JOURNAL OF VIRAL HEPATITIS, 2002, 9 (02) :84-100
[10]   TRANSMISSION OF HEPATITIS-C VIRUS FROM MOTHERS TO INFANTS - ITS FREQUENCY AND RISK-FACTORS REVISITED [J].
MORIYA, T ;
SASAKI, F ;
MIZUI, M ;
OHNO, N ;
MOHRI, H ;
MISHIRO, S ;
YOSHIZAWA, H .
BIOMEDICINE & PHARMACOTHERAPY, 1995, 49 (02) :59-64